Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2014 Dec;99(12):e257–e259. doi: 10.3324/haematol.2014.110437

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© Ferrata Storti Foundation

PMC Copyright notice

Figure 1. — TCF4 expression and survival curves in the first cohort. (A) Expression of TCF4 in AML patients (n=525), NBM (n=5) and hCD34⁺ (n=11). (B) TCF4 expression ranked from lowest to highest expression (n=525). (C) Overall survival (OS) curves for AML patients with available follow-up data (n=518) stratified by TCF4^high (n=129) and TCF4^low (n=389). (D) Same for event-free survival (EFS). (E) OS curves for 7CF4^high AML patients with available follow up and consolidation treatment data (n=129) stratified for conditioning with alloHCT (n=36), autoHCT (n=13) or additional CT (n=80). (F) OS curves for TCF4^low AML patients with available follow up and consolidation treatment data (n=386) stratified for conditioning with alloHCT (n=99), autoHCT (n=57) or additional CT (n=212).